Healthy volunteers help unlock Body's yohimbine processing secrets
NCT ID NCT06939608
First seen Jan 22, 2026 · Last updated May 17, 2026 · Updated 22 times
Summary
This study looked at how the body processes yohimbine differently in men and women based on their CYP2D6 gene type. 36 healthy adults aged 18-40 took a single low dose of yohimbine and caffeine. Researchers measured drug levels in the blood to understand genetic and sex-based differences. The study did not treat any disease and was purely for knowledge.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETIC STUDY IN HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Medicine Greifswald, Institute of Pharmacology
Greifswald, Mecklenburg-Vorpommern, 17489, Germany
Conditions
Explore the condition pages connected to this study.